DESIGN OF AN OPEN-LABEL, MULTICENTRE, NON-INTERVENTIONAL STUDY OF ZONISAMIDE AS FIRST-LINE ADJUNCTIVE TREATMENT IN ADULTS WITH PARTIAL EPILEPSY: THE ZOOM STUDY

被引：0
|
作者：
Baulac, M. [1 ]
Rugg-Gunn, F. [2 ]
Chouette, I. [3 ]
机构：
[1] Neurol Hop Pitie Salpetriere, Paris, France
[2] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[3] Eisai Europe Ltd, Hatfield, Herts, England
来源：
EPILEPSIA | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [41] Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium
    Cornelis, N.
    Vermassen, T.
    Schallier, D.
    Machiels, J. -P.
    Gil, T.
    Debruyne, P. R.
    D'hondt, R.
    Bols, A.
    Schrijvers, D.
    Mebis, J.
    Lumen, N.
    Rottey, S.
    [J]. ACTA CLINICA BELGICA, 2014, 69 (05) : 335 - 340
  • [42] Clinical Usefulness of Diquafosol for Real-World Dry Eye Patients: A Prospective, Open-Label, Non-Interventional, Observational Study
    Yamaguchi, Masahiko
    Nishijima, Takeshi
    Shimazaki, Jun
    Takamura, Etsuko
    Yokoi, Norihiko
    Watanabe, Hitoshi
    Ohashi, Yuichi
    [J]. ADVANCES IN THERAPY, 2014, 31 (11) : 1169 - 1181
  • [43] Survey of safety and efficacy of long-acting injectable risperidone in daily practice: An open-label, non-interventional prospective study
    Parellada, E.
    Filippos, K.
    Siurkute, A.
    Don, L.
    Medori, R.
    Lex, A.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 154 - 154
  • [44] SURVEY OF SAFETY AND EFFICACY OF LONG-ACTING INJECTABLE RISPERIDONE IN DAILY PRACTICE: AN OPEN-LABEL, NON-INTERVENTIONAL PROSPECTIVE STUDY
    Parellada, E.
    Kouniakis, F.
    Siurkute, A.
    Schreiner, A.
    Don, L.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [45] Once-Daily OROS Hydromorphone for Management of Cancer Pain: An Open-Label, Multi-Center, Non-Interventional Study
    Park, Cheol Kyu
    Kang, Hyun-Wook
    Oh, In-Jae
    Kim, Young-Chul
    Kim, Yeo-Kyeoung
    Na, Kook-Joo
    Ahn, Sung-Ja
    Kim, Tae Ok
    Choi, Young Jin
    Song, Geun Am
    Lee, Min Ki
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (12) : 1914 - 1921
  • [46] Clinical Usefulness of Diquafosol for Real-World Dry Eye Patients: A Prospective, Open-Label, Non-Interventional, Observational Study
    Masahiko Yamaguchi
    Takeshi Nishijima
    Jun Shimazaki
    Etsuko Takamura
    Norihiko Yokoi
    Hitoshi Watanabe
    Yuichi Ohashi
    [J]. Advances in Therapy, 2014, 31 : 1169 - 1181
  • [47] Age-related evaluation of clinical manifestation and treatment of von Willebrand disease evaluated in an open-label, prospective, non-interventional study (wilate®-set)
    Miesbach, W.
    Alesci, S.
    Feddern, J.
    Kadar, J.
    Von Depka, M.
    Scharrer, I.
    [J]. HAEMOPHILIA, 2012, 18 : 196 - 196
  • [48] Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy
    Gaston, Tyler E.
    Szaflarski, Magdalena
    Hansen, Barbara
    Bebin, E. Martina
    Szaflarski, Jerzy P.
    [J]. EPILEPSY & BEHAVIOR, 2019, 95 : 10 - 17
  • [49] Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with VigabatrinFinal Results from an Open-Label, Observational, Multicentre Study
    John M. Wild
    Catherine Chiron
    Hyosook Ahn
    Michel Baulac
    Joseph Bursztyn
    Enrico Gandolfo
    Ivan Goldberg
    Francisco Javier Goñi
    Florence Mercier
    Jean-Philippe Nordmann
    Avinoam B. Safran
    Ulrich Schiefer
    Emilio Perucca
    [J]. CNS Drugs, 2009, 23 : 965 - 982
  • [50] An open-label, multi-center phase IIIb study of durvalumab and tremelimumab as first-line treatment in patients with unresectable hepatocellular carcinoma (TREMENDOUS study).
    Fan, Jia
    Qin, Shukui
    Sun, Hui-Chuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS628 - TPS628
12345